Emberton M - Search Results

1

To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?

Uchida T, Illing RO, Cathcart PJ, Emberton M. Uchida T, et al. Among authors: emberton m. BJU Int. 2006 Sep;98(3):537-9. doi: 10.1111/j.1464-410X.2006.06297.x. BJU Int. 2006. PMID: 16925749

2

A description of radical nephrectomy practice and outcomes in England: 1995-2002.

Nuttall M, Cathcart P, van der Meulen J, Gillatt D, McIntosh G, Emberton M. Nuttall M, et al. Among authors: emberton m. BJU Int. 2005 Jul;96(1):58-61. doi: 10.1111/j.1464-410X.2005.05567.x. BJU Int. 2005. PMID: 15963121

3

When thinking of initiating medical therapy for lower urinary tract symptoms, ask about cataracts.

Cathcart P, Rajendram R, Rajendram R, Emberton M. Cathcart P, et al. Among authors: emberton m. BJU Int. 2005 Dec;96(9):1217-8. doi: 10.1111/j.1464-410X.2005.06027.x. BJU Int. 2005. PMID: 16287433 No abstract available.

4

Definition of at-risk patients: dynamic variables.

Emberton M. Emberton M. BJU Int. 2006 Apr;97 Suppl 2:12-5; discussion 21-2. doi: 10.1111/j.1464-410X.2006.06099.x. BJU Int. 2006. PMID: 16507047 Review.

5

Trends in paediatric circumcision and its complications in England between 1997 and 2003.

Cathcart P, Nuttall M, van der Meulen J, Emberton M, Kenny SE. Cathcart P, et al. Among authors: emberton m. Br J Surg. 2006 Jul;93(7):885-90. doi: 10.1002/bjs.5369. Br J Surg. 2006. PMID: 16673355

6

Incidence of primary and recurrent acute urinary retention between 1998 and 2003 in England.

Cathcart P, van der Meulen J, Armitage J, Emberton M. Cathcart P, et al. Among authors: emberton m. J Urol. 2006 Jul;176(1):200-4; discussion 204. doi: 10.1016/S0022-5347(06)00509-X. J Urol. 2006. PMID: 16753401

7

The thermo-expandable metallic stent for managing benign prostatic hyperplasia: a systematic review.

Armitage JN, Rashidian A, Cathcart PJ, Emberton M, van der Meulen JH. Armitage JN, et al. Among authors: emberton m. BJU Int. 2006 Oct;98(4):806-10. doi: 10.1111/j.1464-410X.2006.06399.x. Epub 2006 Jul 28. BJU Int. 2006. PMID: 16879446 Review.

8

The effect of neoadjuvant androgen suppression on prostate cancer-related outcomes after high-intensity focused ultrasound therapy.

Uchida T, Illing RO, Cathcart PJ, Emberton M. Uchida T, et al. Among authors: emberton m. BJU Int. 2006 Oct;98(4):770-2. doi: 10.1111/j.1464-410X.2006.06369.x. Epub 2006 Jul 28. BJU Int. 2006. PMID: 16879448

9

Deciding the future of British urology.

Illing RO, Emberton M. Illing RO, et al. Among authors: emberton m. BJU Int. 2006 Aug;98(2):252-3. doi: 10.1111/j.1464-410X.2006.06292.x. BJU Int. 2006. PMID: 16879660 No abstract available.

10

The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis.

Blake-James BT, Rashidian A, Ikeda Y, Emberton M. Blake-James BT, et al. Among authors: emberton m. BJU Int. 2007 Jan;99(1):85-96. doi: 10.1111/j.1464-410X.2006.06574.x. Epub 2006 Oct 9. BJU Int. 2007. PMID: 17026588 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

567 results

Search Page

Filters